Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Charles Smith
Medical University of South Carolina, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Apogee Biotechnology Corporation
Salary not from the awardee Institution
Project involves compounds owned by Apogee Biotechnology Corp. The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
The overall goal of this Program Project is to determine common mechanisms that are inter-regulated by sphingosine 1-phosphate (S1P) signaling that induces cancer cell proliferation, resistance to stress-induced apoptosis, and metastasis to distant organs, and to utilize this mechanistic information for the development of novel therapeutic strategies to treat patients with solid tumors by targeting specific S1P signaling cascades.
Filed on August 11, 2016.
Tell us what you know about Charles Smith's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Charles Smith”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Charles Smith | Medical University of South Carolina | Conflict of Interest | Apogee Biotechnology Corporation | $0 - $4,999 |
| Charles Smith | Medical University of South Carolina | Conflict of Interest | Apogee Biotechnology Corporation | Value cannot be readily determined |
| Harold Charles Smith | Oyagen, Inc. | Conflict of Interest | University of Rochester | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.